Comparison of the Efficacy of Denosumab and Alendronate in Improving Bone Mineral Density in Osteoporosis Patients and High-Risk Populations: A Systematic Review and Meta-Analysis
Puntos clave
Denosumab shows a greater improvement in bone mineral density compared to alendronate.
The review included studies involving various populations at high risk for osteoporosis-related fractures.
Meta-analysis conducted across multiple studies provides comprehensive data on treatment effects.
This analysis highlights the need for further research to confirm long-term outcomes associated with both medications.
Me gusta
Guardar
Compartir
Me gusta
Guardar
Compartir
Comparison of the Efficacy of Denosumab and Alendronate in Improving Bone Mineral Density in Osteoporosis Patients and High-Risk Populations: A Systematic Review and Meta-Analysis | Synapse